In addition, MMKD led to improved CSF profiles of AD pathological markers as demonstrated by increased Aβ42, decreased total tau, and increased Aβ42/tau ratio, again pointing towards the positive effect of MMKD on CSF AD biomarker profiles [42]. Here, MAPT is linked to Alzheimer disease.